{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-24-000094","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2024-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.724207+00:00","generated_at":"2026-05-31T15:59:42.542619+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"GRI Bio increases ATM offering capacity to $2.64M, reports $961K already sold","bullets":["Maximum aggregate gross proceeds from ATM offering raised to $2,644,609 via prospectus supplement filed July 26, 2024.","Approximately $961,272 of shares have already been sold under the May 20, 2024 Sales Agreement with H.C. Wainwright & Co.","Shares are common stock, par value $0.0001 per share; proceeds used for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-24-000094","json":"https://secwatch.observer/filing/0001824293-24-000094.json","markdown":"https://secwatch.observer/filing/0001824293-24-000094.md","text":"https://secwatch.observer/filing/0001824293-24-000094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000094/0001824293-24-000094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429324000094/val-20240726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:59:42.542619+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}